VINORELBINE AN vinorelbine (as tartrate) 50 mg/5 mL concentrated injection vial

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

vinorelbine tartrate, Quantity: 69.25 mg (Equivalent: vinorelbine, Qty 50 mg)

Pieejams no:

Amneal Pharma Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Vinorelbine tartrate

Zāļu forma:

Injection, concentrated

Kompozīcija:

Excipient Ingredients: water for injections

Ievadīšanas:

Intravenous Infusion

Vienības iepakojumā:

Pack of 10 x 5 mL vials, Pack of 5 x 5 mL vials, Pack of 1 x 5 mL vial

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as a first line treatment for advanced non-small cell lung cancer, as a single agent or in combination.

Produktu pārskats:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Licence status A

Autorizācija datums:

2012-01-18